Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

ZUMA-12: A phase 2 study of axi-cel as first-line therapy in patients with high...

Prof Sattva Neelapu - The University of Texas MD Anderson Cancer Center...

ZUMA-12: A phase 2 study of axi-cel as first-line therapy in patients with high-risk large B-cell lymphoma (LBCL) ( Prof Sattva Neelapu - The University of Texas MD Anderson Cancer Center, Houston, USA )

Potentially targetable pathways ID’d for augmenting CAR-T cell therapy for DLBCL

Prof Brian Hill - Cleveland Clinic, Cleveland, USA

Potentially targetable pathways ID’d for augmenting CAR-T cell therapy for DLBCL ( Prof Brian Hill - Cleveland Clinic, Cleveland, USA )

Mosunetuzumab induces deep and durable remissions in 3L R/R follicular lymphoma

Prof Elizabeth Budde - City of Hope, Duarte, USA

Mosunetuzumab induces deep and durable remissions in 3L R/R follicular lymphoma ( Prof Elizabeth Budde - City of Hope, Duarte, USA )

Study indicates circulating tumour cell assessment should be part of multiple...

Dr Juan-José Garcés - Clinica Universidad de Navarra, Pamplona, Spain

Study indicates circulating tumour cell assessment should be part of multiple myeloma diagnostic workup ( Dr Juan-José Garcés - Clinica Universidad de Navarra, Pamplona, Spain )

Initial treatment options for relapsed/refractory multiple myeloma patients

Dr Maria-Victoria Mateos - University Hospital of Salamanca-IBSAL, Salamanca...

$Initial treatment options for relapsed/refractory multiple myeloma patients ( Dr Maria-Victoria Mateos - University Hospital of Salamanca-IBSAL, Salamanca, Spain )$

ZUMA-5 update: Axicabtagene ciloleucel continues to show strong effect in R/R...

Prof Sattva Neelapu - The University of Texas MD Anderson Cancer Center...

ZUMA-5 update: Axicabtagene ciloleucel continues to show strong effect in R/R iNHL ( Prof Sattva Neelapu - The University of Texas MD Anderson Cancer Center, Houston, USA )

Lisocabtagene maraleucel demonstrates improvement over standard of care in 2L...

Dr Manali Kamdar - The University of Colorado Anschutz Medical Campus, Aurora...

Lisocabtagene maraleucel demonstrates improvement over standard of care in 2L LBCL ( Dr Manali Kamdar - The University of Colorado Anschutz Medical Campus, Aurora, USA )

Latest in advanced endometrial cancer

Prof Isabelle Ray-Coquard, Prof Christian Marth, Prof David Cibula, Prof Ignace...

Latest in advanced endometrial cancer ( Prof Isabelle Ray-Coquard, Prof Christian Marth, Prof David Cibula, Prof Ignace Vergote )

Oncology nursing in the global south during COVID-19

Dr Julia Challinor and Prof Annie Young

Oncology nursing in the global south during COVID-19 ( Dr Julia Challinor and Prof Annie Young )

OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

Post-HSCT management of ALL - Adult ALL perspective

Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain

Post-HSCT management of ALL - Adult ALL perspective ( Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain )

Quality of life and patient perspectives in renal cell carcinoma

Prof Steven Hildemann, Dr Rachel Giles and Prof Gunhild von Amsberg

Quality of life and patient perspectives in renal cell carcinoma ( Prof Steven Hildemann, Dr Rachel Giles and Prof Gunhild von Amsberg )

More from ecancer